{
  "retracted": false,
  "timestamp": 1501545600000,
  "updates": [
    {
      "timestamp": 1581640813238,
      "identifier": {
        "doi": "10.1212/wnl.0000000000004316"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1212/wnl.0000000000002889"
  },
  "publisher": "Ovid Technologies (Wolters Kluwer Health)",
  "title": "Transplantation of spinal cord-derived neural stem cells for ALS: Analysis of phase 1 and phase 2 trials"
}
